Bevan P., Lorens S., Archer T. (1989) Behavioural pharmacology of 5-HT: possible progress in the laterality of concepts. In Bevan P , Cools A R, Archer, T (eds), Behavioural pharmacology of 5-HT. LawrenceErlbaum Assoc, Inc., pp. 459-474
2.
Bobillier R., Seguin S., Petitjean G., Salvert D., Touret M., Jouvet M. (1976) The raphe nuclei of the cat brainstem: a topographical atlas of their efferent projections as revealed by autoradiography. Brain Res113: 449-486
3.
Davis M. (1986) Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav Neurosci100: 814-824
4.
Davis M., Astrachan D.J., Kass E. ( 1980) Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle. Science209: 521-523
5.
Davis M., Kehne J.H., Commissaris R.L., Geyer M.A. (1984) Effects of hallucinogens on unconditioned behaviors . In Jacobs B L (ed.) Halucinogens: neurochemical, behavioral and clinical perspectives, Raven Press, New York, pp. 35-75
6.
Davis M., Cassella J.V., Kehne J.H. (1983) Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology94: 14-21
7.
Geyer M.A., Puerto A., Dawsey W.J., Knapp S., Bullard W.P., Mandell A.J. (1976a) Histologic and enzymatic studies on the mesolimbic and mesostriatal serotonergic pathways. Brain Res106: 241-256
8.
Geyer M.A., Puerto A., Menkes D.B., Segal D.S., Mandell A.J. (1976b) Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res106: 256-270
9.
Geyer, M.A. (1976) Functional heterogeneity within neurotransmitter systems. Psychopharmacol Commun,1: 675-685
10.
Geyer, M.A., Petersen, L.R., Rose, G.J., Horwitt D.D., Light R.K., Adams L.M., Zook J.A., Hawkins R.L. and Mandell A.J. (1978) The effects of LSD and mescaline-derived hallucinogens on sensory-integrative function: Tactile startle. J Pharmacol Exp Ther, 207: 837-847
11.
Geyer, M.A. and Tapson G.S. (1988) Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacology, 1: 135-147
12.
Geyer M.A. (1978) Heterogenous functions of discrete serotonergic pathways in brain. In Usdin E and Mandell A J (eds), New Vistas in the Biochemistry of Mental Disorders. Marcel Dekker, New York, pp. 233-260
13.
Grillon C., Ameli R. and Davis M. (1991) The fear-potentiated startle reflex as a measure of fear onset and offset. Biol Psychi.29: 144A
14.
Hitchcock J. and Davis M. (1986) Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behav Neurosci100: 11-22
15.
Jacobs B.L., Wise W.D. and Taylor K.M. (1974) Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res.79: 353-361
16.
Lorens S.A., Guldberg H.C. (1974) Regional 5-hydroxytryptamine following selective midbrain raphe lesions in the rat. Brain Res78: 45-56
17.
Mansbach R.S. and Geyer M.A. (1988) Blockade of potentiated startle responding in rats by 5-hydroxytryptamine 1A receptor ligands. Eur J Pharmacol156: 375-383
18.
Olpe H.R., Koelle W.P. (1977) The response of striatal cells upon stimulation of the dorsal and median raphe nuclei. Brain Res322: 357-360
